A risk score for chronic kidney disease in the general population.
暂无分享,去创建一个
R. D'Agostino | B. Astor | J. Coresh | C. Fox | J. Massaro | J. Meigs | C. O’Seaghdha | A. Lyass | J. Coresh | Asya Lyass
[1] A. Kribben,et al. How does late nephrological co‐management impact chronic kidney disease? – An observational study , 2010, International journal of clinical practice.
[2] Hsiu-Ching Hsu,et al. A prediction model for the risk of incident chronic kidney disease. , 2010, The American journal of medicine.
[3] Uwe Völker,et al. New loci associated with kidney function and chronic kidney disease , 2010, Nature Genetics.
[4] Marcello Tonelli,et al. Early recognition and prevention of chronic kidney disease , 2010, The Lancet.
[5] G. Curhan. Prediabetes, prehypertension ... is it time for pre-CKD? , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[6] Cory Swingen,et al. MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: Methods, reliability and descriptive statistics , 2010, Journal of magnetic resonance imaging : JMRI.
[7] A. Köttgen,et al. Defining incident chronic kidney disease in the research setting: The ARIC Study. , 2009, American journal of epidemiology.
[8] Yurii S. Aulchenko,et al. Multiple loci associated with indices of renal function and chronic kidney disease , 2009, Nature Genetics.
[9] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[10] A. Folsom,et al. Blood pressure, atherosclerosis, and albuminuria in 10 113 participants in the Atherosclerosis Risk In Communities study , 2009, Journal of hypertension.
[11] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[12] R. Garrick. A Simple Algorithm to Predict Incident Kidney Disease , 2009 .
[13] Rajiv Saran,et al. Patient awareness of chronic kidney disease: trends and predictors. , 2008, Archives of internal medicine.
[14] V. Bellizzi,et al. [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.
[15] B. Brenner,et al. Renal risk scores: progress and prospects. , 2008, Kidney international.
[16] Malorye Allison,et al. Is personalized medicine finally arriving? , 2008, Nature Biotechnology.
[17] T. Nickolas,et al. Biomarkers in acute and chronic kidney disease , 2008, Current opinion in nephrology and hypertension.
[18] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[19] L. Stevens,et al. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] Neil R. Powe,et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. , 2007, Kidney international.
[21] A. Levey,et al. CKD: common, harmful, and treatable--World Kidney Day 2007. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] B. Brenner,et al. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. , 2006, Kidney international.
[23] Michael M Engelgau,et al. Chronic Kidney Disease: A Public Health Problem That Needs a Public Health Action Plan , 2006, Preventing chronic disease.
[24] G. Eknoyan,et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.
[25] T. Larson,et al. Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.
[26] R. D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions , 2004, Statistics in medicine.
[27] Daniel Levy,et al. Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.
[28] John M. Lachin,et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.
[29] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[30] F. Locatelli,et al. The importance of early detection of chronic kidney disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[32] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[34] C. Schmid,et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. , 2001, Annals of internal medicine.
[35] D. Levy,et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. , 2000, The American journal of medicine.
[36] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[37] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[38] B. Freedman,et al. Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.
[39] D. Hosmer,et al. A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.
[40] Aric Invest. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .
[41] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[42] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[43] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.